Honeywell recently introduced Aclar Accel, a new, cost-effective thermoformable barrier film for pharmaceutical packaging. Honeywell’s Aclar gives companies cost-effective alternatives for product packaging with increased shelf life, decreased operating costs and protection of drugs in climates throughout the world.
While the original Aclar is clear & customizable, Aclar Accel 1700 maintains the clarity, but has a standard size that allows for faster production. Aclar Accel 5400 is designed for opaque laminates and offers an even denser, moisture-rich barrier to companies seeking a more cost-effective solution to protect drugs than cold form foil in aluminium blister packaging, which has higher production costs and slower output.
“Pharmaceutical companies are seeking new packaging technologies that allow them to get their drugs to market faster and reduce operational costs and Aclar Accel addresses those needs,” said Ken West, Vice President & General Manager, Packaging & Composites, Honeywell.
In comparison to packages made from cold form foil, Aclar enables smaller blister pack sizes that reduce shelf space, usage of raw materials and lower transportation costs. Available in many thickness grades and a wide range of moisture barriers, Aclar provides flexibility to optimize moisture protection across different climate conditions.
Honeywell’s Aclar films are based on polychlorotrifluoroethylene (PCTFE) fluoropolymer technology. They are clear, biochemically inert, chemical-resistant, nonflammable, and plasticizer- and stabilizer free. The films can facilitate increased patient compliance with doctor prescriptions with see-through, portable and patient-friendly pack presentations. Currently, Aclar thermoformable films are used in a broad range of markets including originator and generic pharmaceutical, over-the-counter (OTC) pharmaceutical and animal health packaging.